November 23, 2016 - By Louis Casey · 0 Comments
The stock of Agilent Tech Incorporated (NYSE:A) registered a decrease of 7.51% in short interest. A’s total short interest was 5.01M shares in November as published by FINRA. Its down 7.51% from 5.42 million shares, reported previously. With 1.87 million shares average volume, it will take short sellers 3 days to cover their A’s short positions. The short interest to Agilent Tech Incorporated’s float is 1.55%. The stock decreased 1.13% or $0.51 during the last trading session, hitting $44.46. Agilent Technologies Inc (NYSE:A) has risen 6.03% since April 21, 2016 and is uptrending. It has outperformed by 0.70% the S&P500.
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The company has a market cap of $14.40 billion. The Firm serves the life sciences, diagnostics and applied chemical markets. It has a 31.65 P/E ratio. It has three business divisions: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Insitutional Activity: The institutional sentiment decreased to 0.93 in Q2 2016. Its down 0.02, from 0.95 in 2016Q1. The ratio turned negative, as 39 funds sold all Agilent Technologies Inc shares owned while 189 reduced positions. 48 funds bought stakes while 168 increased positions. They now own 266.26 million shares or 3.79% less from 276.75 million shares in 2016Q1.
Impax Asset Management Ltd owns 1.64 million shares or 3.63% of their US portfolio. Wells Fargo Com Mn last reported 1.42 million shares in the company. The Missouri-based Stifel Fin has invested 0.01% in Agilent Technologies Inc (NYSE:A). Bonness Enterp accumulated 22,300 shares or 0.83% of the stock. Moreover, National Pension Service has 0.09% invested in Agilent Technologies Inc (NYSE:A) for 241,119 shares. Cambridge Investment Rech, a Iowa-based fund reported 8,624 shares. Ibm Retirement Fund accumulated 0.06% or 38,545 shares. Welch & Forbes Ltd last reported 0.01% of its portfolio in the stock. Capstone Asset Management last reported 0.06% of its portfolio in the stock. Pitcairn accumulated 0.06% or 10,516 shares. Carroll Assoc has 0% invested in the company for 352 shares. Glg Lc last reported 0.07% of its portfolio in the stock. Guardian Life Insur Of America accumulated 1,226 shares or 0% of the stock. Pathstone Family Office Lc holds 0.02% or 389 shares in its portfolio. Marshall Wace Llp holds 37,405 shares or 0.01% of its portfolio.
Insider Transactions: Since May 27, 2016, the stock had 0 insider purchases, and 6 insider sales for $1.42 million net activity. Shares for $94,000 were sold by Kaltenbach Patrick on Wednesday, August 31. On Friday, May 27 CULLEN JAMES sold $764,389 worth of the stock or 16,697 shares. Gonsalves Rodney also sold $389,303 worth of Agilent Technologies Inc (NYSE:A) on Monday, August 29. FIELDS HEIDI also sold $379,303 worth of Agilent Technologies Inc (NYSE:A) on Tuesday, September 6. Another trade for 4,704 shares valued at $213,138 was sold by CLARK PAUL N. 5,298 shares were sold by KOH BOON HWEE, worth $252,503.
Out of 10 analysts covering Agilent Technologies (NYSE:A), 7 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 70% are positive. $55 is the highest target while $39 is the lowest. The $47.30 average target is 6.39% above today’s ($44.46) stock price. Agilent Technologies has been the topic of 22 analyst reports since August 14, 2015 according to StockzIntelligence Inc. The stock of Agilent Technologies Inc (NYSE:A) earned “Buy” rating by Goldman Sachs on Tuesday, December 8. The firm has “Buy” rating given on Friday, August 14 by BTIG Research. As per Thursday, August 18, the company rating was maintained by Cowen & Co. The firm has “Buy” rating given on Tuesday, August 25 by TheStreet. On Thursday, August 18 the stock rating was maintained by Goldman Sachs with “Buy”. The stock of Agilent Technologies Inc (NYSE:A) earned “Outperform” rating by Cowen & Co on Thursday, May 26. The stock has “Buy” rating given by BTIG Research on Thursday, August 18. Goldman Sachs maintained the stock with “Buy” rating in Wednesday, May 11 report. Robert W. Baird upgraded it to “Outperform” rating and $48 target price in Wednesday, December 9 report. On Thursday, January 7 the stock rating was upgraded by Cowen & Co to “Outperform”.
Agilent Technologies, Inc., incorporated on May 4, 1999, provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Firm serves the life sciences, diagnostics and applied chemical markets. The Firm has three business divisions: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. The life sciences and applied markets business segment brings together the Company’s analytical laboratory instrumentation and informatics. The Company’s diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. The Company’s Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
More recent Agilent Technologies Inc (NYSE:A) news were published by: Marketwatch.com which released: “Agilent Technologies gives downbeat guidance” on November 15, 2016. Also Businesswire.com published the news titled: “Agilent Technologies and PureHoney Technologies to Develop New Applications …” on November 01, 2016. Investorplace.com‘s news article titled: “3 Stocks to Watch on Wednesday: Aclaris Therapeutics Inc (ACRS), Agilent …” with publication date: November 16, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Louis Casey